Pyoderma
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Dioxidin Versus Miramistin in Superficial Pyoderma (NCT05561816) | Valenta Pharm JSC | 2022-07-19 |
| Phase 0/1 Local Application of the Monoclonal Antibody (Mab) sB24M in Patients With Purulent Pyoderma (NCT04895566) | SWISS BIOPHARMA MED GmbH | 2021-05-24 |
| Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460) (NCT00202891) | Merck Sharp & Dohme LLC | 2007-05-01 |
| Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory (NCT00884728) | Menzies School of Health Research | 2004-09-01 |
Track Pyoderma automatically
Every clearance here is in the API, with alerts when new ones post.